DBV Technologies relocates facility to Paris:
This article was originally published in Clinica
DBV Technologies, headquartered in Boulogne, France, is moving its operational facility to central Paris in a bid to expand R&D efforts and its workforce. The new facility will house up to 80 staff. The company is currently developing its patented Viaskin epicutaneous delivery technology, for use in the diagnosis and treatment of allergies.